SUPN
Supernus Pharmaceuticals Inc
Price:  
29.10 
USD
Volume:  
625,388.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SUPN DCF Valuation - Growth Exit 5Y

-122.7%
Upside

The Discounted Cash Flow (DCF) valuation of Supernus Pharmaceuticals Inc (SUPN) is (6.62) USD. With the latest stock price at 29.10 USD, the upside of Supernus Pharmaceuticals Inc based on DCF is -122.7%.

Note: valuation result may not be accurate due to the low predictability of business.

Range Selected
WACC / Discount Rate 5.4% - 7.0% 6.2%
Long-term Growth Rate 3.0% - 5.0% 4.0%
Fair Price (37.06) - (3.31) (6.62)
Upside -227.3% - -111.4% -122.7%
29.10 USD
Stock Price
(6.62) USD
Fair Price